Norwegian FSA 1 min read

Tematilsyn - Informerer foretakene godt nok om IFRS 18?

RegCanary analysis of a Norwegian FSA publication

Representative image

Why it matters

RegCanary's analysis of what this means for regulated firms.

While the review is a supervisory diagnostic rather than an enforcement action, the signal to markets is clear: the regulator expects issuers to be well advanced in their implementation programmes and to communicate entity-specific, decision-useful information about expected impacts on primary statements, subtotals and disaggregation. For compliance, financial reporting and investor relations teams, the practical implication is that boilerplate 'we are assessing the impact' language is unlikely to satisfy supervisory expectations in the next reporting cycle. Issuers should be able to articulate the anticipated effects on the statement of profit or loss — particularly the new operating/investing/financing categories and mandated subtotals — on the statement of cash flows, and on the intensity of disaggregation in the notes.

This requires early gap analysis against current accounting policies, system and chart-of-accounts changes, updated KPIs and non-GAAP measure reconciliations, and refreshed audit committee oversight. Groups with Norwegian listings, Nordic subsidiaries of international issuers, and dual-listed entities should treat this as a cross-border disclosure quality issue, since comparable reviews are underway in other European jurisdictions. Audit committees should challenge whether transition disclosures are specific enough to withstand regulatory scrutiny, and finance teams should coordinate with auditors and valuers well ahead of comparative-period restatement.

Firms that move early can differentiate themselves through higher-quality, transparent communication and a smoother, lower-cost transition, while laggards face the prospect of supervisory follow-up letters, restatement risk and reputational damage with investors. No firm-specific deadlines are set out in the notice, but the direction of travel is unambiguous: preparation and disclosure quality are now under active supervisory review.

Who this affects

Sectors and firm types identified in the analysis.

  • General Regulation

Source

Norwegian FSA

Original publication, 21 October 2026

Read the original publication (opens in a new tab) finanstilsynet.no

This is RegCanary's analysis, not the regulator's text. It summarises and interprets the publication above; it is not the Norwegian FSA's original wording, and it is not legal advice. Always rely on the original source.

Share

Weekly Briefing

Get the weekly briefing.

The regulatory changes that matter, with RegCanary analysis of what they mean for your firm. Delivered every Friday. Unsubscribe anytime.

Need this tailored to your firm's permissions? Book a demo